3049 companies

Dx & Vx

Market Cap: ₩119.6b

Engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea.

A180400

₩2,455.00

7D

-4.5%

1Y

-25.6%

Hunan Jingfeng PharmaceuticalLtd

Market Cap: CN¥5.1b

Manufactures and sells chemical drugs and biological agents in China.

000908

CN¥5.77

7D

4.9%

1Y

32.9%

ChoA Pharmaceutical

Market Cap: ₩39.3b

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea.

A034940

₩1,234.00

7D

10.2%

1Y

-9.9%

Enzychem Lifesciences

Market Cap: ₩86.6b

Engages in developing novel small molecule therapeutics for patients with unmet needs for oncology, inflammatory, and severe respiratory diseases in South Korea.

A183490

₩1,129.00

7D

5.1%

1Y

-22.5%

Nxera Pharma

Market Cap: JP¥90.3b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

4565

JP¥974.00

7D

1.0%

1Y

-24.6%

Mirxes Holding

Market Cap: HK$11.1b

A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.

2629

HK$44.28

7D

-1.2%

1Y

n/a

PaxMedica

Market Cap: US$25.2k

A clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.

PXMD

US$0.0002

7D

0%

1Y

-99.8%

Argent BioPharma

Market Cap: AU$8.3m

A clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally.

RGT

AU$0.10

7D

-25.0%

1Y

-67.7%

Zhejiang Taimei Medical Technology

Market Cap: HK$2.6b

Zhejiang Taimei Medical Technology Co., Ltd.

2576

HK$4.55

7D

-7.1%

1Y

n/a

Red White & Bloom Brands

Market Cap: CA$16.5m

Manufactures, processes, and distributes cannabis products and accessories in the United States, Canada, and international territories.

RWB

CA$0.035

7D

0%

1Y

-50.0%

ANG Lifesciences India

Market Cap: ₹369.8m

Manufactures and sells pharmaceuticals products and formulations in India.

540694

₹29.64

7D

17.3%

1Y

-52.8%

BF Biosciences

Market Cap: PK₨14.6b

A diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products.

BFBIO

PK₨166.23

7D

-2.5%

1Y

n/a

Indofarma

Market Cap: Rp390.5b

Manufactures and sells pharmaceutical products in Indonesia and internationally.

INAF

Rp126.00

7D

0%

1Y

-74.3%

Maverick Lifestyle

Market Cap: US$45.4m

Engages in the manufacture, branding, marketing, distribution, and sale of products infused with hemp-derived cannabinoids in the United States.

MVRK

US$4.75

7D

n/a

1Y

n/a

MYND Life Sciences

Market Cap: CA$5.2m

A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

MYND

CA$0.07

7D

0%

1Y

n/a

Cannabis Bioscience International Holdings

Market Cap: US$6.8m

Cannabis Bioscience International Holdings, Inc.

CBIH

US$0.0006

7D

-1.6%

1Y

-14.3%

Impact BioMedical

Market Cap: US$7.8m

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.

IBO

US$0.64

7D

7.4%

1Y

n/a

Real Brands

Market Cap: US$269.9k

Produces and sells hemp cannabinoids oil and related products.

RLBD

US$0.0001

7D

9,900.0%

1Y

-98.7%

Aspire Biopharma Holdings

Market Cap: US$21.3m

An early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States.

ASBP

US$0.43

7D

-25.2%

1Y

-96.2%

Bio-Thera Solutions

Market Cap: CN¥12.8b

A biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally.

688177

CN¥30.83

7D

-9.2%

1Y

53.2%

Chiome Bioscience

Market Cap: JP¥9.4b

Engages in the research and development of drug discovery technology platforms worldwide.

4583

JP¥134.00

7D

-2.9%

1Y

10.7%

WOOJUNG BIO

Market Cap: ₩29.7b

Provides non-clinical research agency services.

A215380

₩1,754.00

7D

4.1%

1Y

-29.6%

GC Cell

Market Cap: ₩298.9b

Develops cell therapy products.

A144510

₩19,910.00

7D

4.5%

1Y

-36.7%

Tus-Pharmaceutical Group

Market Cap: CN¥2.9b

Manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China.

000590

CN¥12.00

7D

2.5%

1Y

130.3%

China NT Pharma Group

Market Cap: HK$802.4m

An investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China.

1011

HK$1.21

7D

34.4%

1Y

404.2%

Jacobio Pharmaceuticals Group

Market Cap: HK$9.1b

An investment holding company, engages in the in-house discovery and development of oncology therapies.

1167

HK$10.85

7D

3.1%

1Y

545.8%

NKMAX

Market Cap: ₩172.7b

Manufactures and sells biological products in South Korea.

A182400

₩2,020.00

7D

0%

1Y

-69.5%

Estrella Immunopharma

Market Cap: US$38.2m

A clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.

ESLA

US$1.03

7D

-3.7%

1Y

3.0%

Deva Holding

Market Cap: ₺12.9b

Manufactures, markets, and sells pharmaceutical products in Turkey.

DEVA

₺64.30

7D

-3.8%

1Y

-3.5%

Kaya Holdings

Market Cap: US$831.3k

A vertically integrated legal cannabis enterprise, operates psychedelic treatment clinics and medical cannabis dispensaries in the United States.

KAYS

US$0.02

7D

53.8%

1Y

-56.7%

Emmaus Life Sciences

Market Cap: US$734.5k

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

EMMA

US$0.011

7D

-8.0%

1Y

475.0%

Bespoke Extracts

Market Cap: US$2.7m

Together with its subsidiary, Bespoke Extracts Colorado, LLC, produces and sells pre-rolled marijuana cigarettes in the United States.

BSPK

US$0.24

7D

23.1%

1Y

152.6%

XTL Biopharmaceuticals

Market Cap: ₪38.8m

A biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.

XTLB

₪0.044

7D

4.8%

1Y

-55.6%

Pharmagreen Biotech

Market Cap: US$663.6k

Operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America.

PHBI

US$0.001

7D

-9.1%

1Y

-25.9%

Allied

Market Cap: US$1.3m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

ALID

US$0.011

7D

0%

1Y

-87.5%

Vectus Biosystems

Market Cap: AU$3.9m

Engages in the medical research and development activities in Australia.

VBS

AU$0.073

7D

0%

1Y

-8.8%

Page 68 of 85